Purchase Order 75H71023P01433

Award Date 7/11/23
Potential Completion Date 7/31/25
Potential Value $561K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chinle, AZ 86503, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $286,617.93 firm fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for cost per test and supplies. The contract has a period of performance through July 31, 2023 and does not have a set-aside designation. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contracts and task orders to...
This is a sole source contract awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for cost per test and supplies. The contract has a ceiling value of $98,811.48 and was awarded on December 29, 2020 as a firm fixed price purchase order. The contract is for the lease of one FLM2-SRV-0001 instrument and associated supplies for the laboratory department at the Chinle...
This contract was awarded by the Department of Health and Human Services (HHS) Indian Health Service (IHS) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the provision of laboratory bio-fire supplies. The contract is a firm-fixed price purchase order with a potential value of $2,364,710.15 and a performance period ending on March 14, 2024. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards to...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit organization. The $149,038.88 contract is for a lab lease agreement and supplies, with a completion date of October 31, 2018. Biofire Diagnostics LLC is a biotech company that specializes in syndromic infectious disease testing and has received numerous federal contracts to provide a variety of related goods and services,...
This federal contract award was made by the Department of Health and Human Services Indian Health Service to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $218,091.46 Firm Fixed Price purchase order is for CCHCF-FY2019 CH-LAB PRIORITY A CPT (BIOFIRE- IHS5419217) services to be delivered by December 31, 2019. The contract does not have a set-aside designation. Biofire Diagnostics LLC holds several indefinite...
This firm fixed-price purchase order was awarded by the Indian Health Service, a civilian agency, to Biofire Diagnostics LLC, a for-profit foreign-owned company, to provide a molecular biology analyzer. The $20,752.50 contract has an ultimate completion date of October 31, 2021. It was awarded on September 10, 2020 and does not have a set-aside designation. The contract was issued against Biofire Diagnostics' General Services Administration Federal Supply Schedule contract for in-vitro...
This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC for the provision of a BIOFIRE ANALYZER, KITS AND PANELS, and UNO SERVICE UNIT to support COVID-19 response efforts. The award, valued at $57,100.00, has an ultimate completion date of October 31, 2021. Biofire Diagnostics LLC is a foreign-owned, for-profit organization that specializes in syndromic infectious...
This is a Delivery Order (DO) awarded by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services, to Biofire Diagnostics LLC. The DO is for COVID-19 testing panels and kits, and is issued under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The total ceiling value of this order is $68,984. Biofire Diagnostics LLC is a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. This order does...
This federal contract award, valued at $267,240.00, was issued by the Indian Health Service (IHS) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The contract is for the provision of support services, parts, maintenance, phone support, on-site services, and software updates for Biofire's infectious disease testing products and services. The contract is a firm fixed-price purchase order with a period of performance through September 25, 2028. No set-aside designation was...
Biofire Diagnostics LLC was awarded a $287,260.21 firm fixed price purchase order by the Department of Health and Human Services Indian Health Service for cost per test and supplies. Biofire Diagnostics LLC is a prime contractor that specializes in syndromic infectious disease testing and has developed molecular diagnostic testing services and products. The place of performance is Chinle, Arizona. No set-aside designation was used for this award made against Biofire's existing General Services...

This is a $561,344.47 firm fixed-price purchase order contract awarded by the Indian Health Service, a civilian agency, to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company. The contract is for the provision of cost-per-test and supplies for the Laboratory Department at the Chinle Comprehensive Health Care Facility, with a period of performance through July 31, 2025. This award is not associated with a set-aside program. Biofire Diagnostics has been awarded numerous federal contracts, primarily with the Department of Veterans Affairs, Defense Health Agency, and Department of State, for its advanced molecular diagnostic testing solutions, including the FilmArray system and associated reagents and services.

Generated 5/30/25, 9:58 AM